KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
Highlights •Wild-type KRAS expression affects cellular fitness in KRAS mutant LUAD •Wild-type KRAS expression impairs response to MEK inhibitors in KRAS mutant LUAD •Wild-type KRAS